Segment Information (Tables)

9 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

Segment revenue, operating (loss) income, and depreciation and amortization were as follows:

	Three Months Ended June 30,						Nine Months Ended June 30,
(In thousands)	2024			2023			2024			2023
Revenue:
Medical Device	$	23,383		$	46,014		$	71,754		$	84,739
In Vitro Diagnostics		6,958			6,469			21,097			19,875
Total revenue	$	30,341		$	52,483		$	92,851		$	104,614
Operating (loss) income:
Medical Device	$	(2,288	)	$	21,777		$	(2,210	)	$	7,483
In Vitro Diagnostics		3,153			2,866			9,633			9,450
Total segment operating income		865			24,643			7,423			16,933
Corporate		(6,234	)		(3,231	)		(12,455	)		(9,333	)
Total operating (loss) income	$	(5,369	)	$	21,412		$	(5,032	)	$	7,600
Depreciation and amortization:
Medical Device	$	1,958		$	1,997		$	5,928		$	5,883
In Vitro Diagnostics		92			78			285			230
Corporate		76			76			342			252
Total depreciation and amortization	$	2,126		$	2,151		$	6,555		$	6,365